# Octagos Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/octagos-health

- Industry: Healthcare IT
- Headquarters: Houston, US
- Website: www.octagoshealth.com
- Total disclosed funding: $29M
- Latest round: Series B (Jul 3, 2024)
- Investors on record: 2

## About

Based in Texas, US, and founded in 2020 by CEO Shanti Bansal, Octagos Health, Inc., a.k.a. Octagos Health operates as a healthcare technology company that focuses on providing remote cardiac monitoring software for patients and medical professionals to improve patient outcomes by leveraging AI-driven solutions. In July 2024, Octagos Health raised USD 43 million in a Series B funding led by Morgan Stanley Expansion Capital, with participation from Mucker Capital.

Octagos Health offers remote cardiac monitoring services, allowing clinics to monitor patients' heart conditions through a single interface. The company provides cardiac monitoring software that supports various devices and includes features like automated data processing, procedure recommendations, and analytics for atrial fibrillation and heart failure. Octagos Health's platform provides real-time tracking of heart rhythm and patient data, ensuring urgent issues are promptly identified. Additionally, the firm offers wearable cardiac monitoring devices that provide treatment recommendations based on established guidelines. The company’s services are compatible with most insurance providers and Medicare, ensuring broad accessibility and coverage for patients.

The company plans to use its proceeds from July 2024 funding to accelerate enhancements to its platform, in addition to scaling its commercial team and operations.

## Funding rounds

- Series B, Jul 3, 2024, $29M — Mucker Capital, Morgan Stanley Expansion Capital

## Investors

- Mucker Capital (https://capitalatlas.ai/funds/mucker-capital) — Series B
- Morgan Stanley Expansion Capital (https://capitalatlas.ai/funds/morgan-stanley-expansion-capital) — Series B